Children, Families, and Health Care Decision Making

ISBN13: 9780199251544ISBN10: 0199251541 Paperback, 216 pages

Also available:

Hardback
Apr 2002,  In Stock

Price:

$50.00 (06)

See more from the series

Description

Ross here presents an original and controversial look at the moral principles that guide parents in making health care decisions for their children, and the role of children in the decision-making process. She opposes the current movement to increase child autonomy, in favor of respect for family autonomy and proposes significant changes in what informed consent allows and requires for pediatric health care decisions. The first systematic medical ethics book that focuses specifically on children's health care, Ross's work has important things to say to health care providers who work with children as well as to ethicists and public policy analysts.

Reviews

"Will surely spark lively debate around our cultural assumptions about individual autonomy, the role of families in society, and our responsibilities to children. ... Ross's book is a welcome contribution to emerging debates about health-care issues involving children"--National Catholic Bioethics Quarterly

" . . . strongly recommend[ed] to anyone who wants to gain valuable insight into the ethical issues involving the child as a research subject, as an organ donor, as a patient, and as a sexually active adolescent."-Laurence D. Houlgate, Ethics

Product Details

216 pages; ISBN13: 978-0-19-925154-4ISBN10: 0-19-925154-1

About the Author(s)

Lainie Friedman Ross, Associate Professor in the Department of Pediatrics and Medicine, and Assistant Director of the Maclean Center for Clinical Medical Ethics, University of Chicago

Add to Cart button
Add to Cart button

Consider these titles...

Children in Medical Research

$110.00 Hardback Mar 2006
What should the rules be governing medical research on children?

Moral Status

$55.00 Paperback Mar 2000
What are the criteria for having moral status?

Drugs and Justice

$21.95 Paperback Oct 2007
A compact and innovative book that tackles one of the central issues in drug policy: the lack of a coherent conceptual structure for thinking about drugs